QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: How EU Pharmaceutical Legislation Is Structured

Test your understanding of the concepts covered by How EU Pharmaceutical Legislation Is Structured.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Which statement best describes the role of a template in EU regulatory work?

A template normally creates the underlying statutory obligation. A template standardises how information is presented, while legislation or guidance determines what information is required and the rationale for it. A template has greater legal force than the regulation under which it is used. A template can replace the need to identify the applicable procedure.

Question 2 of 10 A professional searches EudraLex for the legal basis of a pharmacovigilance obligation. What is the most appropriate use of the collection?

Treat every EudraLex document as having the same legal force. Start with relevant legislation, such as material in Volume 1, and distinguish it from guidance and notices in other volumes. Use only Volume 2 because all pharmacovigilance requirements are guidance-based. Assume that inclusion in EudraLex converts a guideline into legislation.

Question 3 of 10 What is the most accurate description of the relationship between Regulation (EC) No 726/2004 and Directive 2001/83/EC?

They are interchangeable names for the same legal instrument. The regulation applies only to scientific guidance, while the directive applies only to national fees. They structure different but interconnected parts of the EU medicines framework, and the relevant product route and procedure determine which provisions apply. The directive automatically repeals the regulation for all post-authorisation matters.

Question 4 of 10 Which information set most effectively supports an auditable regulatory conclusion?

Document title and a general description of the agency's position Instrument, issuing authority, legal basis and effect, together with the relevant provision and version or date A link to a secondary article without identifying the primary source The name of the product and the date of the internal discussion only

Question 5 of 10 Which source should normally control the final answer to a question about the exact legal requirement imposed by an EU medicines provision?

A secondary educational summary An agency FAQ, regardless of its wording The applicable primary legal text, interpreted in its relevant context An outdated internal procedure copied from a previous product

Question 6 of 10 Which statement best describes the practical legal distinction between an EU regulation and a directive in medicines regulation?

A regulation binds only Member States that choose to adopt it, whereas a directive applies automatically to companies. A regulation is binding in its entirety and directly applicable, whereas a directive binds Member States as to the result and generally requires national implementation. A directive is always more legally authoritative than a regulation because it permits national flexibility. A regulation provides only scientific guidance, whereas a directive establishes enforceable procedures.

Question 7 of 10 What is the principal function of an implementing act compared with a delegated act?

It creates primary EU law independently of any basic legislative act. It provides uniform conditions for implementing legally binding Union acts within the framework established by EU law. It replaces all national implementation of directives. It records the scientific reasoning of a regulatory committee without legal effect.

Question 8 of 10 An amendment is published on 1 June, enters into force on 21 June and applies from 1 January of the following year, subject to transitional provisions. Which date is most relevant when deciding whether a new obligation applies to a submission made in July?

The publication date only The entry-into-force date only The date of application together with any relevant transitional provisions The date on which the agency first publishes a summary

Question 9 of 10 A regulatory professional is assessing a nationally authorised medicine and needs to determine the applicable national administrative powers. Which source combination is most appropriate?

Only Regulation (EC) No 726/2004, because all medicines regulation is centralised at EU level. Only an EMA guideline, because administrative powers are described in procedural guidance. Directive 2001/83/EC together with the relevant national implementing legislation and administrative rules. Only the product's assessment report, because it records the complete legal framework.

Question 10 of 10 A QPPV is evaluating whether a pharmacovigilance system meets an EU requirement. Which sequence best reflects the article's recommended approach?

Begin with a GVP module, then determine whether legislation exists. Begin with the applicable legislation, then use the relevant GVP module and current procedural guidance to operationalise the assessment. Begin with a press release, because it states the regulator's current expectations. Begin with national law only, because pharmacovigilance is never governed by EU legislation.

Knowledge Assessment: How EU Pharmaceutical Legislation Is Structured

Cookie Settings